Impax Laboratories, Inc.
(NASDAQ : IPXL)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
AGNAllergan plc
0.02%174.872.9%$652.65m
TEVATeva Pharmaceutical Industries Limited Sponsored ADR
4.64%14.112.1%$414.12m
ZTSZoetis, Inc. Class A
-0.01%71.061.9%$201.11m
MYLMylan N.V.
-0.50%37.093.1%$185.85m
IPXLImpax Laboratories, Inc.
0.59%17.0510.8%$22.07m
TXMDTherapeuticsMD, Inc.
-1.32%5.9727.8%$17.67m
TAROTaro Pharmaceutical Industries Ltd.
0.52%110.636.2%$16.91m
RDYDr. Reddy's Laboratories Ltd. Sponsored ADR
-0.56%35.672.0%$12.99m
ABEOAbeona Therapeutics, Inc.
0.00%16.158.0%$12.75m
PETXAratana Therapeutics, Inc.
0.42%7.139.6%$2.63m
KINKindred Biosciences, Inc.
0.68%7.400.4%$0.66m
JAGXJaguar Animal Health, Inc.
-2.55%0.176.6%$0.57m
BSPMBioStar Pharmaceuticals, Inc.
-1.10%1.8011.8%$0.31m
LFVNLifeVantage Corporation
-0.19%5.253.3%$0.22m
CPHIChina Pharma Holdings, Inc.
-0.06%0.180.1%$0.06m

Company Profile

Impax Laboratories, Inc. operates as a technology based specialty pharmaceutical company, which engages in the development, manufacture, and marketing of controlled-release and niche generics. It operates through the Impax Generics and Impax Specialty Pharma segments. The Impax Generics segment concentrates on the development manufacture, sale and distribution of generic products, which are the pharmaceutical and therapeutic equivalents of brand-name drug products and are usually marketed under their established nonproprietary drug names rather than by a brand name. The Impax Specialty Pharma segment engages in the development of proprietary brand pharmaceutical products. The company was founded on December 14, 1999 and is headquartered in Hayward, CA.